Search Press releases Keywords From To 1 May 2026 UCB announces acquisition of IMIDomics’ Patient Insight Business, strengthening capabilities in immune-mediated inflammatory diseases (IMIDs) Read More 30 Apr 2026 UCB’s General Meeting of Shareholders 2026 Read More 24 Apr 2026 Acquisition of own shares Read More 17 Apr 2026 Acquisition of own shares Read More 17 Apr 2026 UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science Read More 15 Apr 2026 UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting Read More Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Page 1 of 63 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe